2025
SJR Q2
JCR Q3 · 1,3
39 matched articles
SCIE
Journal detail
Neuropathology
- Publisher
- Wiley-Blackwell Publishing Ltd
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
0919654414401789
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,538
- Quartile Q2
- H-Index 74
- Cites/doc 1,38
- Docs (3y) 178
- Cites (3y) 272
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 1,3
- 5Y JIF 1,6
- JCI 0,41
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Medicine (miscellaneous) Q2
- Neurology (clinical) Q3
- Pathology and Forensic Medicine Q2
Areas
- Medicine
WoS categories
- Clinical Neurology | Neurosciences | Pathology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,538 | 1,3 | 1,6 | 0,41 | Q4 | 74 |
| 2024 | Q2 | Q3 | 0,497 | 1,2 | 1,6 | 0,42 | Q3 | 72 |
| 2023 | Q2 | Q3 | 0,641 | 1,3 | 1,7 | 0,48 | Q3 | 72 |
| 2022 | Q2 | Q3 | 0,666 | 2,3 | 2 | 0,5 | Q3 | 72 |
| 2021 | Q2 | Q3 | 0,615 | 2,1 | 2,2 | 0,49 | Q3 | 72 |
| 2020 | Q2 | Q3 | 0,701 | 1,9 | 2,2 | 0,56 | Q3 | 72 |
| 2019 | Q2 | Q3 | 0,66 | 1,8 | 1,7 | 0,65 | Q3 | 72 |
| 2018 | — | Q2 | — | 2,2 | 1,9 | 0,72 | Q2 | — |
| 2017 | Q1 | Q3 | 0,952 | 1,9 | 1,6 | 0,64 | Q3 | 72 |
| 2016 | Q2 | Q3 | 0,743 | 1,8 | 1,6 | — | — | 72 |
| 2015 | Q2 | Q3 | 0,788 | 1,6 | 1,6 | — | — | 72 |
| 2014 | Q2 | Q3 | 0,762 | 1,7 | 1,6 | — | — | 72 |
| 2013 | Q1 | Q3 | 0,942 | 1,8 | 1,7 | — | — | 72 |
| 2012 | Q2 | Q3 | 0,781 | 1,9 | 1,7 | — | — | 72 |
| 2011 | Q1 | Q2 | 0,833 | 2 | 1,8 | — | — | 72 |
| 2010 | Q2 | Q3 | 0,684 | 1,6 | 1,7 | — | — | 72 |
| 2009 | — | Q3 | — | 1,9 | 1,8 | — | — | — |
| 2008 | — | Q3 | — | 1,7 | 1,7 | — | — | — |
| 2007 | — | Q3 | — | 1,3 | 1,4 | — | — | — |
| 2006 | — | Q3 | — | 1,3 | — | — | — | — |
| 2005 | — | Q3 | — | 1,2 | — | — | — | — |
| 2004 | — | Q3 | — | 1,2 | — | — | — | — |
| 2003 | — | Q4 | — | 0,6 | — | — | — | — |
| 2002 | — | Q3 | — | 1 | — | — | — | — |
| 2001 | — | Q4 | — | 0,6 | — | — | — | — |
| 2000 | — | Q4 | — | 0,5 | — | — | — | — |
| 1999 | — | Q4 | — | 0,4 | — | — | — | — |
| 1998 | — | Q3 | — | 0,7 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | CLINICAL NEUROLOGY | SCIE | Q4 | Q4 | 240/296 |
| 2025 | NEUROSCIENCES | SCIE | Q4 | Q4 | 299/330 |
| 2025 | PATHOLOGY | SCIE | Q3 | Q4 | 64/89 |
| 2024 | CLINICAL NEUROLOGY | SCIE | Q4 | Q4 | 232/286 |
| 2024 | NEUROSCIENCES | SCIE | Q4 | Q4 | 286/314 |
| 2024 | PATHOLOGY | SCIE | Q3 | Q3 | 63/90 |
| 2023 | CLINICAL NEUROLOGY | SCIE | Q4 | Q3 | 223/280 |
| 2023 | NEUROSCIENCES | SCIE | Q4 | Q4 | 277/310 |
| 2023 | PATHOLOGY | SCIE | Q3 | Q3 | 61/88 |
| 2022 | CLINICAL NEUROLOGY | SCIE | Q3 | Q3 | 151/212 |
| 2022 | NEUROSCIENCES | SCIE | Q4 | Q4 | 215/272 |
| 2022 | PATHOLOGY | SCIE | Q3 | Q3 | 43/76 |
| 2021 | CLINICAL NEUROLOGY | SCIE | Q4 | Q3 | 173/212 |
| 2021 | NEUROSCIENCES | SCIE | Q4 | Q4 | 240/275 |
| 2021 | PATHOLOGY | SCIE | Q3 | Q3 | 55/77 |
| 2020 | CLINICAL NEUROLOGY | SCIE | Q4 | Q3 | 170/208 |
| 2020 | NEUROSCIENCES | SCIE | Q4 | Q4 | 237/273 |
| 2020 | PATHOLOGY | SCIE | Q3 | Q3 | 57/77 |
| 2019 | CLINICAL NEUROLOGY | SCIE | Q3 | Q3 | 153/204 |
| 2019 | NEUROSCIENCES | SCIE | Q4 | Q3 | 224/272 |
| 2019 | PATHOLOGY | SCIE | Q3 | Q3 | 50/78 |
| 2018 | CLINICAL NEUROLOGY | SCIE | Q3 | Q2 | 131/199 |
| 2018 | NEUROSCIENCES | SCIE | Q3 | Q3 | 198/267 |
| 2018 | PATHOLOGY | SCIE | Q2 | Q2 | 35/76 |
| 2017 | CLINICAL NEUROLOGY | SCIE | Q3 | Q3 | 140/197 |
| 2017 | NEUROSCIENCES | SCIE | Q4 | Q3 | 205/261 |
| 2017 | PATHOLOGY | SCIE | Q3 | Q3 | 45/79 |
| 2016 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 135/194 |
| 2016 | NEUROSCIENCES | SCIE | Q4 | — | 202/259 |
| 2016 | PATHOLOGY | SCIE | Q3 | — | 44/79 |
| 2015 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 142/193 |
| 2015 | NEUROSCIENCES | SCIE | Q4 | — | 209/256 |
| 2015 | PATHOLOGY | SCIE | Q3 | — | 47/79 |
| 2014 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 134/192 |
| 2014 | NEUROSCIENCES | SCIE | Q4 | — | 195/252 |
| 2014 | PATHOLOGY | SCIE | Q3 | — | 48/76 |
| 2013 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 120/194 |
| 2013 | NEUROSCIENCES | SCIE | Q4 | — | 190/252 |
| 2013 | PATHOLOGY | SCIE | Q3 | — | 46/76 |
| 2012 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 104/193 |
| 2012 | NEUROSCIENCES | SCIE | Q3 | — | 185/252 |
| 2012 | PATHOLOGY | SCIE | Q3 | — | 41/77 |
| 2011 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 104/192 |
| 2011 | NEUROSCIENCES | SCIE | Q3 | — | 171/244 |
| 2011 | PATHOLOGY | SCIE | Q2 | — | 35/79 |
| 2010 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 113/185 |
| 2010 | NEUROSCIENCES | SCIE | Q4 | — | 188/239 |
| 2010 | PATHOLOGY | SCIE | Q3 | — | 43/76 |
| 2009 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 96/167 |
| 2009 | NEUROSCIENCES | SCIE | Q3 | — | 168/231 |
| 2009 | PATHOLOGY | SCIE | Q3 | — | 36/71 |
| 2008 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 94/156 |
| 2008 | NEUROSCIENCES | SCIE | Q3 | — | 163/221 |
| 2008 | PATHOLOGY | SCIE | Q3 | — | 38/69 |
| 2007 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 99/146 |
| 2007 | NEUROSCIENCES | SCIE | Q4 | — | 164/211 |
| 2007 | PATHOLOGY | SCIE | Q3 | — | 47/66 |
| 2006 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 98/147 |
| 2006 | NEUROSCIENCES | SCIE | Q4 | — | 159/200 |
| 2006 | PATHOLOGY | SCIE | Q3 | — | 40/64 |
| 2005 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 94/148 |
| 2005 | NEUROSCIENCES | SCIE | Q4 | — | 158/200 |
| 2005 | PATHOLOGY | SCIE | Q3 | — | 42/66 |
| 2004 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 84/140 |
| 2004 | NEUROSCIENCES | SCIE | Q4 | — | 151/198 |
| 2004 | PATHOLOGY | SCIE | Q3 | — | 41/65 |
| 2003 | CLINICAL NEUROLOGY | SCIE | Q4 | — | 116/135 |
| 2003 | NEUROSCIENCES | SCIE | Q4 | — | 171/198 |
| 2003 | PATHOLOGY | SCIE | Q4 | — | 58/64 |
| 2002 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 83/138 |
| 2002 | PATHOLOGY | SCIE | Q3 | — | 43/64 |
| 2001 | CLINICAL NEUROLOGY | SCIE | Q4 | — | 107/136 |
| 2001 | PATHOLOGY | SCIE | Q4 | — | 53/66 |
| 2000 | CLINICAL NEUROLOGY | SCIE | Q4 | — | 111/137 |
| 2000 | PATHOLOGY | SCIE | Q4 | — | 57/67 |
| 1999 | CLINICAL NEUROLOGY | SCIE | Q4 | — | 110/132 |
| 1998 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 85/125 |